Determinants of successful clinical networks: the conceptual framework and study protocol by Haines, Mary et al.
STUDY PROTOCOL Open Access
Determinants of successful clinical networks: the
conceptual framework and study protocol
Mary Haines
1,2*, Bernadette Brown
1, Jonathan Craig
2, Catherine D’Este
3, Elizabeth Elliott
4, Emily Klineberg
4,
Elizabeth McInnes
5, Sandy Middleton
5, Christine Paul
6, Sally Redman
1 and Elizabeth M Yano
7, for
on behalf of Clinical Networks Research Group
Abstract
Background: Clinical networks are increasingly being viewed as an important strategy for increasing evidence-
based practice and improving models of care, but success is variable and characteristics of networks with high
impact are uncertain. This study takes advantage of the variability in the functioning and outcomes of networks
supported by the Australian New South Wales (NSW) Agency for Clinical Innovation’s non-mandatory model of
clinical networks to investigate the factors that contribute to the success of clinical networks.
Methods/Design: The objective of this retrospective study is to examine the association between external support,
organisational and program factors, and indicators of success among 19 clinical networks over a three-year period
(2006-2008). The outcomes (health impact, system impact, programs implemented, engagement, user perception,
and financial leverage) and explanatory factors will be collected using a web-based survey, interviews, and record
review. An independent expert panel will provide judgements about the impact or extent of each network’s
initiatives on health and system impacts. The ratings of the expert panel will be the outcome used in multivariable
analyses. Following the rating of network success, a qualitative study will be conducted to provide a more in-
depth examination of the most successful networks.
Discussion: This is the first study to combine quantitative and qualitative methods to examine the factors that
contribute to the success of clinical networks and, more generally, is the largest study of clinical networks
undertaken. The adaptation of expert panel methods to rate the impacts of networks is the methodological
innovation of this study. The proposed project will identify the conditions that should be established or
encouraged by agencies developing clinical networks and will be of immediate use in forming strategies and
programs to maximise the effectiveness of such networks.
Background
The role of clinical networks in improving evidence-based
practice
It is widely accepted that patients who receive evidence-
based care achieve better outcomes. However, despite
increases in more rigorous clinically relevant research,
the slow and haphazard uptake or failure to adopt such
evidence into practice persists [1,2].
Clinical networks are more commonly being viewed as
an important strategy for increasing evidence-based
practice and improving models of care [3]. It is argued
that clinical networks provide ‘bottom up’ views on the
best ways to tackle complex healthcare problems and
can facilitate or champion changes in practice at the
clinical interface [3,4]. Most clinical networks are estab-
lished to improve the quality of and access to care for
patients, including those who require care across a
range of care settings. The term clinical network has
been used to describe many variants of networks, ran-
ging from fully integrated service delivery systems to
informal communities of practice [3]. In this study, we
define the term clinical networks to mean voluntary
clinician groupings that aim to improve clinical care and
service delivery using a collegial approach to identify
and implement a range of strategies. * Correspondence: mary.haines@saxinstitute.org.au
1Sax Institute, Haymarket, Australia
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the study
An example of such an approach in Australia is the New
South Wales (NSW) Agency for Clinical Innovation’s (the
Agency) non-mandatory model of clinical networks. The
Australian health system is a mix of public and private pro-
viders. The federal government is responsible for national
initiatives and policies, regulation, and funding, while the
state governments are responsible for the delivery and
management of hospital services. The Agency is a board-
governed statutory organisation funded by the NSW State
Health Department that has been fully operational since
2004, serving as a mechanism for bringing about clinical
change and improved health outcomes. These networks
vary in clinical focus (e.g., stroke care, ophthalmology, and
urology), size (43-708 members), and length of operation
(14-113 months) [5]. Each network is chaired by clinicians,
has a Network Manager employed by the Agency, and
implements its chosen activities in association with the
State Health Department and the relevant area health ser-
vice/s. (Further operational details are provided in Table 1
and in a recent Sax Institute report [5].)
The evidence gap: What makes clinical networks
successful?
Some clinical networks are more effective than others.
Clinical networks can engage clinicians in service redesign
and reform [6,7], develop and implement protocols [6,7],
develop and implement guidelines [8-10], facilitate knowl-
edge sharing [9], and design and implement quality-
improvement programs that result in improved quality of
care in hospitals [7,8,10]. However, other research has
reported that clinical networks have not had an impact
[6]. In studies evaluating more than one network, varying
success between networks has been reported [11], with
others being unable to sustain improvements after the
funding cycle ended [12].
Much of the research into clinical networks focuses on
describing the establishment and activities of single net-
works [3]. Few studies have aimed to identify critical
factors that determine the effectiveness of a network [11].
A recent Swedish qualitative study compared factors
associated with three successful clinical networks with
three networks that did not develop successfully [13].
Three major determinants of developing a successful net-
work were identified: professional dedication, legitimacy,
and confidence. However, this study examined only a
small number of networks, provided limited information
regarding study design and methods, and did not quan-
tify the strength of any observed association.
Given their widespread implementation and data indi-
cating variable success, there is considerable interest in
understanding how clinical networks can best be estab-
lished and supported to maximise their impact on patient
care and service delivery.
Aim
The study takes advantage of a unique opportunity pro-
vided by the Agency’s non-mandatory model of clinical
networks to investigate the factors that contribute to the
success of clinical networks. Multiple coexisting networks,
such as those operating under the Agency, provide an
opportunity to holistically examine the range of factors
that affect the success of clinical networks.
Research objective and hypotheses
The objective of this study is to investigate the external
support, organisational, and program factors associated
Table 1 The New South Wales Agency for Clinical Innovation clinical network model
Network Feature Description of Network Model
Goal The goals of the networks are to improve health services and health outcomes by developing services based on clinical
need, improving the quality of care and safety for patients, increasing equity of access and equity of outcomes within the
hospital system, and enabling clinician-and consumer-driven planning.
Membership The clinical networks are composed of volunteer health professionals across a range of clinical areas to disseminate
knowledge on evidence-based care.
Structure The networks are free to select those issues that they believe will be effective in improving care. Each network is chaired
by clinicians, has a Network Manager employed by the Agency, and implements activities in association with State Health
Department and the Area Health Services.
Inputs to support
networks
To support the networks, the Agency provides
￿ funds to employ a Network Manager and approximately AUD$30000 for small projects and operations;
￿ training and support for the Network Managers;
￿ funds for larger-scale projects on a competitive basis of approximately AUD$100000 (per project);
￿ accommodation and office facilities for the Network Managers, most of whom are located together in the main Agency
office;
￿ bimonthly meetings for Network Managers to report on activities, discuss common problems, and share ideas and
potential solutions;
￿ monitoring of progress and feedback by close involvement in network activities, ongoing supervision of managers, and
overview of annual reports from each network that address their activities against their annual plans;
￿ profiling of the work of the networks through formal annual reports.
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tual model described below, success is defined as
follows:
￿ Healthcare impact: The extent to which there is
evidence of impact on healthcare and patient
outcomes.
￿ System impact: The extent to which there is evi-
dence of impact on system-wide change.
￿ Programs: The number of quality-improvement
initiatives undertaken and the quality of their design.
￿ Engagement: The extent of engagement by net-
work members in network activities.
￿ User perception: The extent to which stake-
holders perceive the networks as effective and
valuable.
￿ Financial leverage: T h ev a l u eo fa n ya d d i t i o n a l
resources leveraged.
We hypothesise that clinical networks will be more
successful if they have these features, based on Paul
Bates and colleagues’ theory of change in healthcare
[14]:
(i) A high level of external support from area health
service and hospital management.
(ii) Effective organisation, specifically strong clinical
leadership and efficient internal management.
(iii) Well-designed quality-improvement programs,
specifically those that are based on an analysis of the pro-
blem, have a specific targeted structural or behavioural
change, have an explicit implementation plan, and moni-
tor impact.
Conceptual model
Given the heterogeneity of clinical disciplines and health
conditions focused upon by clinical networks, multiple
metrics of the success of networks is required [15]. For
example, disease-free survival, readmission rates, or mor-
tality rates will vary in applicability for different networks.
A key component of our approach was to develop a
defensible suite of outcomes toj u d g et h es u c c e s s f u l n e s s
of clinical networks that are justifiable to scientific, clini-
cal, and policy communities.
In partnership with the Agency board, executive, and
staff, the research team iteratively developed the program
logic framework that underpins the model of the
Agency’s networks. Figure 1 shows the ways in which the
actions of the networks are anticipated to improve
healthcare and health outcomes. This logic, the outcomes
of successful networks, and explanatory factors were
further explored in a qualitative study with 27 stake-
holders [16] of the clinical networks to inform the over-
arching conceptual model for this study and the
subsequent design of data collection methods.
Figure 2 presents a conceptual model linking our
hypothesised outcomes and explanatory factors. The
face validity of this model was confirmed with board
and executive members of the Agency as well as the
managers of the networks.
The outcomes have potential to influence each other,
and in many ways, could be interdependent. For this
model, the outcomes have been grouped into ‘end out-
comes’, which are more long-term indicators of success,
and ‘intermediate outcomes’, which may function as indica-
tors of success independently or as intermediary steps
towards success illustrated in another way. The explanatory
factors underneath the model could be relevant at different
stages along this pathway, potentially having an influence
on the different outcomes. These factors could function to
‘enable’ the outcomes and, as such, could be included in
the model contributing to any of the outcomes.
Methods
Design
This paper describes the protocol for a retrospective study
of the association between external support, organisational,
and program factors (explanatory factors) and indicators of
success (outcomes) among 19 clinical networks over a
three-year period (2006-2008). The unit of analysis for this
study is the network (see Table 1 for more operational
details of the model of clinical networks). This study will
examine initiatives undertaken over a three-year period
between 2006 and 2008. We have selected a three-year
intervention period to balance the time required for evi-
dence of impact against accuracy of recall. At the com-
mencement of the proposed study in 2010, all of the
networks had been in operation for longer than three years
and most for longer than four years. Due to the complexity
of the study, it will include a series of approaches (see
Figure 3 for a study overview). Firstly, information about
the outcomes and exposures will be collected using a web-
based survey, interviews, and record review. Based on these
data, an independent expert panel will provide judgements
about the impact on health and system outcomes. Panel
ratings will be the outcome used in statistical analyses.
Following the rating of network success, a qualitative
study will be conducted, complementing the quantitative
study. This will assist with interpretation of the results by
providing more in-depth examination of factors that con-
tributed to the successful networks. We will purposely
select up to three networks to focus on in more detail. In-
depth interviews with key informants associated with those
networks will explore the reasons for the associations we
may find between explanatory factors and outcomes.
Outcome indicators (see Additional file 1)
￿ Evidence of impact on healthcare and patient
outcomes: This study requires a standard approach
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outcomes, taking into consideration that the net-
works have developed different initiatives focused on
a wide range of different conditions dealt with by
different health services. Using the definition in
Additional file 1 secondary evidence of each net-
work’s impact on healthcare and patient outcomes
will be collected through interviews with network
leaders and managers. This evidence will then be
submitted to the expert panel for rating on the
extent of impact on quality of care and patient out-
comes for each network.
￿ Evidence of impact on system-wide change: The
Institute of Healthcare Innovation in the United
States has advocated for the wider adoption of net-
work initiatives throughout the health system as a
measure of network success [17-19], and this has
been used to assess health system performance
[20,21]. The secondary evidence of each network’s
i m p a c to ns y s t e m - w i d ec h a n g ew i l lb ec o l l e c t e d
through interviews with Network Chairs and Man-
agers. An expert panel will rate the extent of impact
on system-wide change for each network based on
this secondary evidence.
￿ Developed and implemented quality-improve-
ment initiatives: A census of network activities will
be identified through a review of minutes of network
meetings, annual plans, and other relevant existing
documents. Details of quality-improvement initia-
tives will be corroborated through interview and by
sighting secondary supporting evidence [22].
￿ Engagement of multidisciplinary clinicians:
Describing and classifying members of clinical net-
w o r k sh a so f t e nb e e nu s e dt oj u d g et h es u c c e s so f
clinical networks [6,13,23], along with tracking atten-
dances, membership [11,24], and perceptions of
engagement [25] through in-depth interviews and
focus groups [6,9,13,26,27]. We will assess multiple
Inputs
Wider outcomes will 
result from 
successful network 
activity
Taskforce 
Investments/model
Direct change as a result 
of network activity
Outcomes Impacts Strategies
Network activities
Funds to employ 
Network Manager
Funds for small projects 
and operations
Training and support for 
the Network Managers
Funds for larger scale 
projects
Accommodation and 
office facilities
Forums to support 
Network Managers
Monitoring of progress 
and feedback on 
network activity
New guidelines 
developed
New models of care 
designed
New protocols 
developed
Clinical research 
fostered
New uniform data 
collection and 
monitoring established
Advocacy and 
consensus documents 
developed
Develop consumer 
resources
Health System
New guidelines used
New models of care 
implemented
New protocols 
implemented
Clinical research produced 
that influences practice
New resources for health 
services leveraged by 
network activity
Clinician
Perceived value of 
networks
Engagement in network 
activities
New state-wide policies 
based on network 
activity
Improved quality of 
care
Improved patient 
outcomes
Increased workforce 
satisfaction, 
recruitment; and 
retention
NSW= New South Wales
Figure 1 NSW Agency for Clinical Innovation - Clinical Networks Project Logic Framework.
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multidisciplinary 
clinicians
Developed and 
implemented 
quality-
improvement 
initiatives
Well-
designed 
quality-
improvement 
initiatives
Evidence of 
impact on 
healthcare 
and patient 
outcomes
Perceived 
as 
valuable
Perceived 
as 
valuable
Additional 
resources 
leveraged 
into network 
priority areas
Evidence of 
impact on 
system-wide 
change
External 
support
Perceived
leadership
Internal 
management
These factors may be included in models aiming 
to explain the mechanisms linking the outcomes 
of successful networks.
Intermediate outcomes End outcomes
Shaded blue boxes= Explanatory factors
Unshaded red boxes= Outcome factors
Figure 2 Representation of a causal pathway for the outcomes of effective networks.
Qualitative 
Pre-study 
[16]
Program Logic 
of the Networks 
[5]
Conceptual 
Framework 
and Study 
Design
Document 
Review
Web 
Survey
Interviews 
to 
Determine 
Impacts
Expert 
Panel 
Rating of 
Impacts
Quantitative 
Analysis
Qualitative 
Study
Figure 3 Study overview.
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and surveys to assess the extent and depth of
engagement of network members.
￿ Perceived as valuable: Previous studies of clinical
networks have assessed perceptions of the value and
effectiveness of networks using semi-structured inter-
views [6,11] and focus groups [9] with patients, health
service personnel, and clinicians. It is not possible to
use these existing questions verbatim because they are
focused on specific networks, but we will use these as
a guide and draw upon key words and themes from
the qualitative study [16] to design the survey to assess
perceived value.
￿ Leveraged additional resources: Resources
obtained for network activities from other sources
a p a r tf r o mt h eA g e n c yw i l lb ee x t r a c t e df r o mf i n a n -
cial records using audit methods [28].
Explanatory factor indicators (see Additional file 2)
￿ External support: Clinical networks operate within a
complex political, cultural, and organisational context
[13]. Although Turrini and colleagues [29] identified
community cohesion, local support, and participation
as critical factors in the success of networks, few stu-
dies have considered the external context in which
networks operate [12,13]. We developed questions for
our web survey based upon keywords and themes
from the qualitative study [16], which strongly sup-
ported assessing relationships with health agencies as a
determinant of network success. Perception of net-
work members about aspects of external context
defined in Additional file 2 will be assessed through
the web survey.
￿ Perceived leadership: A growing body of research
evidence supports the influence of leadership on the
success of networks [6,9,22,30]. Using a web survey
of network members, we will assess the strength and
quality of the leadership of the network across six
key aspects derived from previous literature (see
Additional file 2).
￿ Internal management: Models of effective health-
care organisations emphasise the importance of effi-
cient internal management [14,31] and the impact of
internal structures (e.g., size, staffing, governance)
and processes for facilitating communication and
knowledge sharing between network members
[9,11,32]. Previous studies of clinical networks have
predominantly used document review and semi-
structured interviews to assess internal management
[9,32,33]. Aspects of internal management of each
network (defined in Additional file 2) will be
assessed through record review and perceptions of
network members in the web survey.
￿ Well-designed quality-improvement initiatives:
Each network will be categorised on how well the
quality-improvement initiatives that contributed to
their main outcomes were designed in terms of the
four criteria detailed in Additional file 2[34].
Data collection methods and samples
￿ Web survey: The aim of the web survey is to assess
network members’ perceptions of value, effectiveness,
leadership, management, external support, and engage-
ment. The web survey has been developed by building
upon appropriate existing measures relating to clinical
networks and those in the wider organisational litera-
ture (see Additional file 2 and above). In addition, all
questions have been tailored to the local context by
taking account of the views and vocabulary elicited in
qualitative exploratory interviews with key stake-
holders who have explicit knowledge of the networks
of the Agency [16]. A record review (Agency minutes
and membership lists) was used to identify a total of
4,280 individuals who participated in the 19 clinical
networks of the Agency from January 2006 to Decem-
ber 2008. All 3,316 network members and participants
with known email addresses will be contacted and
invited to participate in the web survey. The web sur-
vey will ask retrospective questions about the attitudes
and perceptions of network members and participants
during the study period (2006-2008). To aid recall and
minimize recall bias, a number of measures will be
employed, including [35,36] (a) recall prompts to assist
respondents to identify the relevant time period and
(b) recall aids to enable respondents to use recognition
rather than recall as a strategy for reporting specific
activities/quality-improvement initiatives since these
questions may be easier to answer if referring to speci-
fic initiatives.
￿ Interviews: 19 interviews to determine the impacts
of the networks will be conducted with both man-
agers and clinical chairs at the same time for each
network. The aim of this interview is to identify the
most important impacts on quality of care and sys-
tem-wide change that resulted from their network’s
activities between 2006 and 2008. Participants will be
asked (a) to identify the most important impacts, (b)
to explain the importance of each impact, (c) how
their network activities led to that impact, and (d) for
evidence of the impacts. The interview will not be a
qualitative exploration but rather an evidence-gather-
ing activity. The interview will also be recorded as a
back-up (not transcribed). The Network Managers
will also be required to obtain evidence to demon-
strate the impacts and how those impacts relate to
the network activities. Following this interview and
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areas covered in the interview listed above for each
impact will be completed by the study team and
reviewed by Network Managers and Chairs for accu-
racy. These pro formas and associated evidence will
be passed on to the expert panel for rating.
￿ Expert panel: This study will use an adaptation of
the RAND/UCLA (University of California, Los
Angeles) appropriateness method [37,38]. This is a sys-
tematic consensus method that has been widely used
to derive expert consensus on clinical indications. The
traditional use combines expert opinion with a sys-
tematic review of the scientific evidence to determine
whether a given procedure would be appropriate in
specific situations. More recently, the RAND/UCLA
approach has been adapted to assess the appropriate-
ness of quality-improvement initiatives and whether
they would be likely to improve health outcomes or
healthcare quality [39-41]. Lisa Rubenstein and collea-
gues used the method to establish organisational qual-
ity-improvement priorities, focusing on system-based
objectives rather than specific issues within patient
care [40]. The panel will have a chair and four mem-
bers with extensive expertise in system-wide clinical
care and quality-improvement programs as well as the
expert panel method. The panellists were selected
through a voting and nomination process with the
study investigators. In order to ensure independence
of the panel members from the Agency, the study
team members from the Agency were not involved in
the voting and selection of panellists, and all panellists
completed a conflict of interest declaration. Based on
the evidence provided by the networks on quality of
care and system-wide change, the panellists will indivi-
dually rate the importance of each impact on a nine-
point scale. In a moderated meeting, the panel will
then discuss any discrepancies in their scores and
rerate each impact for a final score of overall success.
￿ Document review: T h eA g e n c yh a sk e p td e t a i l e d
records of all meetings and initiatives and provides
regular reports to the NSW Department of Health and
to the Minister. These records will be audited using a
standardised coding schedule, including free-text
annotations, to identify initiatives undertaken and net-
work membership. Additional resources leveraged will
be extracted from income and expenditure statements
in financial records.
Data analysis
Statistical methods–association between outcomes and
exposures
The unit of analysis for this study is the network. Non-
parametric Spearman correlation coefficients will be
obtained to investigate the association between the var-
ious outcomes (to determine if those who score highly
on one outcome also score highly on other outcomes),
between the various explanatory variables, and between
each outcome and each explanatory variable. Other
potential factors that may confound the association
between the hypothesised explanatory factors and out-
comes of clinical networks will be examined. These
include months of operation, Network Manager’sa v e r -
age full-time equivalent working hours during the study
period, turnover of staff, turnover of chairs, budget allo-
cated to network by Agency, and start-up network bud-
get. Multiple linear regression analysis will be
undertaken to examine the relationship between all
exposures and each of the outcomes. Variables will be
included in the regression model if they have a p value
of 0.25 or less on univariate analysis, and a stepwise
process will be used to include/exclude variables until
the final model is determined. Because the number of
observations for these models is small (19), it will not
be possible to include a large number of variables in
each model. Therefore, various models will be generated
for each outcome that consider meaningful groups of
explanatory variables at a time. A significance level of
5% will be used to assess statistical significance in the
final model. If appropriate (i.e., there is variation in pre-
cision of the summary measure estimates), we will use
the method of Kulathinal [42] to adjust for variation in
the measurement errors among networks.
Sample size
There have been no previous quantitative studies exam-
ining the association between organisational and contex-
tual factors and the effectiveness of clinical networks. We
have used data from a recent Australian study examining
the association between clinical performance and organi-
sational determinants in 19 healthcare organisations to
estimate the likely effect size; in this study, Spearman
correlation coefficients for associations of relevance to
our study generally range from 0.45 to 0.71. With 19 net-
works and a 5% significance level, we have 80% power to
detect a correlation coefficient as being statistically signif-
icant if it is 0.6 or more. Thus, we will have sufficient
power to detect moderate to large associations that, given
the findings of Braithwaite [41], are achievable and clini-
cally meaningful.
Qualitative study
The final stage of this study will be a qualitative study to
complement the quantitative results by exploring, from
the viewpoints of key stakeholders, the functions and
relationships between the network features and processes
associated with making an impact on quality of care and
system-wide change. The aim of this study is to develop
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that could then be used to inform future network devel-
opment. The successful impacts within the networks will
be explored, with the aim of gaining insight into the pro-
cess(es) that led to the impact. The results of the analysis
will inform (a) the selection of networks and (b) the
explanatory factors that will be explored qualitatively.
T h ed a t aw i l lb ec o l l e c t e dt h rough individual, face-to-
face semi-structured interviews with key informants
involved in the success of each network. A snowballing
approach to sampling will be used to locate the key infor-
mants, starting with a Network Chair and the Network
Manager from 2006 to 2008. The sample will include a
mix of those connected with the network and those who
are not linked to the network to gain multiple perspec-
tives. The qualitative exploration will involve thematic
analysis of data to identify the main themes that emerge
across the accounts of success as having made an impact.
This study will function to illuminate aspects of the
quantitative analysis and to drill down to identify why
and how those features identified in the quantitative
work contributed to network success.
Discussion
This project will use the unique opportunity provided by
t h ec l i n i c a ln e t w o r k so ft h eN S WA g e n c yo fC l i n i c a l
Innovation to undertake the first quantitative study to
examine the factors that contribute to the success of clin-
ical networks and, more generally, the largest study of
clinical networks undertaken internationally. The mixed-
methods approach combined with the adaptation of
expert panel methods to rate impacts of networks is the
methodological innovation of this study.
Challenges inherent in this study relate to difficulties in
comparing these very different networks–the ‘apples and
oranges’ problem. We need to rate each network’s impact
on quality of care and system-wide change, taking into
account heterogeneity of impacts. A further challenge in
this comparative study will be whether it is possible to
adequately take account of other large differences between
the networks that may influence the impacts they can
achieve, such as the focus and size of their clinical disci-
pline and their stage of operational establishment. Our
methods, as outlined in this protocol, will go some way to
addressing these challenges, but further validation is likely
to be required.
The project is based on a strong working partnership
between the research group and the clinical networks.
This enables the research to be framed around the real-
world operational issues of the networks and for the study
to be designed so it is sensitive to the operational con-
straints of the networks. The research team has expertise
in social and behavioural science, economics, clinical
epidemiology, biostatistics, clinical care, and evaluation of
health service interventions. Furthermore, a number of
members are leaders in the implementation of clinical net-
works (including the CEO, Executive Director, and former
Chair of the Agency). With this combination of collabora-
tors, the study will meet scientific standards and will also
be used by the Agency when setting policy directions for
the networks.
There is an urgent need to understand the factors that
increase the likelihood that clinical networks will be effec-
tive because they are being widely implemented in Austra-
lia and other countries. The proposed project will identify
the conditions that should be established or encouraged
by agencies developing clinical networks and will be of
immediate use in forming strategies and programs to max-
imise the effectiveness of such networks. The findings will
form the basis of strategies to improve less effective net-
works and to ensure that any new networks are estab-
lished as well as possible. The outcomes and tools
developed as part of this project can be adopted by this
Agency and others for ongoing monitoring of impact.
Additional material
Additional file 1: Summary of outcomes, indicators and data
collection method of successful networks.
Additional file 2: Summary of explanatory factors, indicators and
data collection method of successful networks.
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